Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 11.82
+0.02 (0.17%)
Nov 2, 2026, 4:27 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 560.46 million as of November 2, 2026. It is the 29,030th most valuable company in the world and the 377th biggest in Sweden. Its market cap has decreased by 47.76% in one year.
Market Cap
560.46M
Enterprise Value
527.86M
Revenue
2.47M
Global Rank
Country Rank
#377 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 560.46M, an increase of 49.17%. That is a compound annual growth rate of 4.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 560.46M | -57.31% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 938.55M |
| SynAct Pharma AB | 888.13M |
| AlzeCure Pharma AB | 871.51M |
| Infant Bacterial Therapeutics AB | 848.70M |
| Oncopeptides AB | 659.34M |
| FluoGuide | 501.92M |
| Cantargia AB | 475.64M |
| Isofol Medical AB | 406.38M |